Cargando…

The Synergistic Effect of Corticosteroids and Mycophenolic Acid on Chemokines in Orbital Cells From Patients With Graves’ Ophthalmopathy

In recent studies, an improvement of the response rate to therapy has been reported with corticosteroids and mycophenolic acid in patients with Graves’ ophthalmopathy (GO). In GO, retro-orbital cells (fibroblasts, preadipocytes, and extraocular muscle cells) secrete Th1 and Th2 chemokines stimulated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fallahi, Poupak, Ferrari, Silvia Martina, Ragusa, Francesca, Elia, Giusy, Ruffilli, Ilaria, Paparo, Sabrina Rosaria, Patrizio, Armando, Benvenga, Salvatore, Antonelli, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Thyroid
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089901/ http://dx.doi.org/10.1210/jendso/bvab048.1726

Ejemplares similares

FRI530 Immune-Modulation By Rapamycin, Or Mycophenolic Acid, Of Th1 And Th2 Chemokines Secretion In Retro-orbital Cells Of Patients With Graves’ Ophthalmopathy
por: Elia, Giusy, et al.
Publicado: (2023)

MON-594 Report Of A Large Series Of Patients With Graves' Disease (with/without Graves' Ophthalmopathy) And Review Of The Literature, About The Association With Other Autoimmune Diseases
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

Precision Medicine in Graves’ Disease and Ophthalmopathy
por: Elia, Giusy, et al.
Publicado: (2021)

Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy
por: Fallahi, Poupak, et al.
Publicado: (2021)

Oral Liquid L-Thyroxine (L-T4) May Be Better Absorbed in Comparison to L-T4 Tablets in Patients With Lactose Intolerance
por: Fallahi, Poupak, et al.
Publicado: (2021)

MON-625 Serum Tsh Levels Normalisation In Patients With Celiac Disease After The Switch From Oral L-t4 In Tablet Form To L-t4 In Liquid Formulation
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

MON-LB102 Liquid L-Thyroxine Can Maintain Stable TSH Values in Patients with Hypothyroidism: A Prospective Study
por: Fallahi, Poupak, et al.
Publicado: (2019)

Chemokines in hyperthyroidism
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

ODP598 Liquid levothyroxine (L-T4) maintains more stable TSH levels in hypothyroid patients, than tablet L-T4
por: Antonelli, Alessandro, et al.
Publicado: (2022)

PSAT366 Liquid L-thyroxine (L-T4) Formulation Normalizes TSH in Hypothyroid Patients Treated with Tablets L-T4
por: Antonelli, Alessandro, et al.
Publicado: (2022)

FRI487 Oral Liquid L- Thyroxine (L-T4) Is More Effective In Controlling Hypothyroidism, Than L-T4 Tablet, In Patients Submitted To Total Thyroidectomy
por: Fallahi, Poupak, et al.
Publicado: (2023)

MON-566 Early Diagnosis of Lymph Node Metastases by Serum Tg and Neck Ultrasonography, and Long Term Follow Up After Radioiodine and/or Surgical Treatment in Patients with Papillary or Follicular Thyroid Cancer.
por: Fallahi, Poupak, et al.
Publicado: (2019)

MON-564 Patients Thyroidectomized For Thyroid Cancer (without Malabsorption) In Treatment With L-thyroxine (L-T4) In Soft Gel Capsule Formulation
por: Fallahi, Poupak, et al.
Publicado: (2019)

FRI547 Orbital Surgery In Moderate-To-Severe Graves´Ophthalmopathy: Institutional Experience
por: Delfino, Laura, et al.
Publicado: (2023)

Graves’ Disease Following SARS-CoV-2 Vaccination: A Systematic Review
por: Patrizio, Armando, et al.
Publicado: (2022)

MON-565 Patients Thyroidectomized For Thyroid Cancer (without Malabsorption) In Treatment With Oral Liquid L-thyroxine (L-T4) Formulation
por: Fallahi, Poupak, et al.
Publicado: (2019)

Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination
por: Patrizio, Armando, et al.
Publicado: (2022)

Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
por: Fallahi, Poupak, et al.
Publicado: (2019)

ODP533 Graves’ Ophthalmopathy in the Setting of Primary Hypothyroidism
por: Alajmi, Sarah, et al.
Publicado: (2022)

THU668 Euthyroid Graves’ Ophthalmopathy: Case Series
por: Saleh Alfadl, Sultan, et al.
Publicado: (2023)

PSAT358 Graves’ Disease Complicated by Post-Operative Graves’ Ophthalmopathy and Pretibial Myxedema
por: Bowens, Brendan, et al.
Publicado: (2022)

ODP506 Posterior Staphyloma misdiagnosed as unilateral Grave's ophthalmopathy
por: Houri, Muhammad
Publicado: (2022)

Oral L‐thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study
por: Fallahi, Poupak, et al.
Publicado: (2018)

SUN-568 Steroid Induced Psychosis Complicating the Treatment of Graves Ophthalmopathy
por: Babu, Leeba, et al.
Publicado: (2019)

Nutraceuticals in Thyroidology: A Review of in Vitro, and in Vivo Animal Studies
por: Benvenga, Salvatore, et al.
Publicado: (2020)

The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine
por: Antonelli, Alessandro, et al.
Publicado: (2021)

SAT-429 Systemic Safety Analysis of Mycophenolate in Graves’ Orbitopathy
por: Lee, Alan C H, et al.
Publicado: (2020)

PSAT352 A Case Report: Unilateral Graves’ Ophthalmopathy in Euthyroid Patient
por: Eid, Mennaallah, et al.
Publicado: (2022)

FRI553 ICI-induced Thyroid Ophthalmopathy With De Novo Graves’ Disease
por: Moctezuma, Sananda I, et al.
Publicado: (2023)

ODP615 Emergence of Graves’ Ophthalmopathy in the Setting of Sudden Hypothyroidism: Possible Mechanisms Explored
por: Suelto, Jeremy Anne, et al.
Publicado: (2022)

Myoinositol in Autoimmune Thyroiditis
por: Paparo, Sabrina Rosaria, et al.
Publicado: (2022)

Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism
por: Ferrari, Silvia Martina, et al.
Publicado: (2021)

Immune and Inflammatory Cells in Thyroid Cancer Microenvironment
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C?
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

L-T4 Therapy in Enteric Malabsorptive Disorders
por: Fallahi, Poupak, et al.
Publicado: (2021)

SUN-576 Abrupt Switching From Hypertyroidism To Hypothyroidism With Pretibial Myxedema And Acropachy, In Graves’ Ophthalmopathy: Case Report.
por: Ferreira, Eduardo, et al.
Publicado: (2019)

SAT-424 Assessing Content Validity of the Graves’ Ophthalmopathy Quality of Life Questionnaire (GO-QOL) in the United States
por: Stan, Marius N, et al.
Publicado: (2020)

PSAT355 A Case Report Identifying Graves’ Ophthalmopathy in a Myasthenia Gravis Crisis and Response to Teprotumumab
por: Zia, Abdul, et al.
Publicado: (2022)

PSAT357 Preventing Progression of Ophthalmopathy Using a 'Block-Replace' Treatment Strategy in Labile Graves’ Disease
por: Bauer, Jessica, et al.
Publicado: (2022)

SAT-486 A Case of Severe Thyroid Ophthalmopathy Requiring Emergency Orbital Decompression and Total Thyroidectomy
por: Leonard, Talayna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b0l6b7jj1mav0n2m4gtqprmrdh